1.      Swartz MN. Cellulitis. New England Journal of Medicine. 2004;350(9):904-12.

2.      Bisno AL, Stevens  DL. Streptococcal Infections of Skin and Soft Tissues. New England Journal of Medicine. 1996;334 (4):240-6.

3.      Baddour LM. Cellulitis syndromes: an update. International journal of antimicrobial agents. 2000;14(2):113-6.

4.      Nichols RL, Florman S. Clinical presentations of soft-tissue infections and surgical site infections. Oxford University Press; 2001.

5.      Rendi-Wagner P, Schwartz E. Epidemiology of Post‐Travel Illnesses. Tropical Diseases in Travelers. 2009:13-26.

6.      Claeys KC, Lagnf AM, Patel TB, Jacob MG, Davis SL, Rybak MJ. Acute Bacterial Skin and Skin Structure Infections Treated with Intravenous Antibiotics in the Emergency Department or Observational Unit: Experience at the Detroit Medical Center. Infectious Diseases and Therapy. 2015;4(2):173-86.

7.      Chlebicki MP, Oh CC. Recurrent cellulitis: risk factors, etiology, pathogenesis and treatment. Current infectious disease reports.2014;16(9):1-8.

8.      Ki V, Rotstein C. Bacterial skin and soft tissue infections in adults: A review of their epidemiology, pathogenesis, diagnosis, treatment and site of care. The Canadian Journal of Infectious Diseases & Medical Microbiology. 2008;19(2):173-84.

9.      Tiwari AK, Lal R. Study to evaluate the role of severity stratification of skin and soft tissue infections (SSTIs) in formulating treatment strategies and predicting poor prognostic factors. International journal of surgery.12(2):125-33.

10.  Misiakos EP, Bagias G, Patapis P, Sotiropoulos D, Kanavidis P, Machairas A. Current Concepts in the Management of Necrotizing Fasciitis. Frontiers in Surgery. 2014;1:36.

11.  Roje Z, Roje Ž, Matić D, Librenjak D, Dokuzović S, Varvodić J. Necrotizing fasciitis: literature review of contemporary strategies for diagnosing and management with three case reports: torso, abdominal wall, upper and lower limbs. World journal of emergency surgery : WJES. 2011;6:46.

12.  Kilburn SA, Featherstone P, Higgins B, Brindle R. Interventions for cellulitis and erysipelas. Cochrane Database of Systematic Reviews. 2010(6).

13.  Duvanel T, Auckenthaler R, Rohner P, Harms M, Saurat JH. Quantitative cultures of biopsy specimens from cutaneous cellulitis. Arch Intern Med. 1989;149 (2):293-6.

14.  Eriksson B, Jorup-Ronstrom C, Karkkonen K, Sjoblom AC, Holm SE. Erysipelas: clinical and bacteriologic spectrum and serological aspects. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 1996;23(5):1091-8.

15.  Hederstedt B, Holm SE, Norberg R. Extremely high titers of serum antibodies against the streptococcal exoenzyme deoxyribonuclease B. Journal of clinical microbiology. 1980;11(6):720-3.

16.  Leppard BJ, Seal DV, Colman G, Hallas G. The value of bacteriology and serology in the diagnosis of cellulitis and erysipelas. The British journal of dermatology. 1985;112(5):559-67.

17.  Hook EW, 3rd, Hooton TM, Horton CA, Coyle MB, Ramsey PG, Turck M. Microbiologic evaluation of cutaneous cellulitis in adults. Arch Intern Med. 1986;146(2):295-7.

18.  Jorup-Ronstrom C, Britton S, Gavlevik A, Gunnarsson K, Redman AC. The course, costs and complications of oral versus intravenous penicillin therapy of erysipelas. Infection. 1984;12(6):390-4.

19.  Dall L, Peterson S, Simmons T, Dall A. Rapid resolution of cellulitis in patients managed with combination antibiotic and anti-inflammatory therapy. Cutis. 2005;75(3):177-80.

20.  Dupuy A, Benchikhi H, Roujeau JC, Bernard P, Vaillant L, Chosidow O, et al. Risk factors for erysipelas of the leg (cellulitis): case-control study. Bmj. 1999;318(7198):1591-4.